| 000 | 03084nam a2200373 4500 | ||
|---|---|---|---|
| 001 | ESSALUD | ||
| 005 | 20260902145039.0 | ||
| 007 | ta | ||
| 008 | t pe ||||| |||| 00| 0 spa d | ||
| 040 | _aBMG | ||
| 041 | _aeng | ||
| 100 |
_aLimbrick, David D. _eAutor _954408 |
||
| 245 | _aDecompression with or without Duraplasty for Chiari I and Syringomyelia | ||
| 300 | _apáginas: 2015-2025 | ||
| 520 | _aBackground: In children with Chiari type I malformation and syringomyelia, neurosurgical posterior fossa decompression (PFD) provides clinical improvement, but whether duraplasty (incising the dura and placing a dural graft) improves outcomes is unclear. Methods: We conducted a multicenter, cluster-randomized, controlled trial of PFD with duraplasty (PFD-D) as compared with PFD alone. Persons 21 years of age or younger with cerebellar tonsillar ectopia of at least 5 mm and a maximum syrinx diameter of 3.0 to 9.9 mm were enrolled at 38 centers. Centers were cluster-randomized: all the participants within each center underwent the same intervention. The primary outcome was surgical complications within 6 months. Secondary outcomes were clinical improvement, syrinx reduction, and repeat decompression at 10 to 24 months and the change in overall health-related quality of life at 6 to 24 months. Results: A total of 162 participants were included in the trial, of whom 78 were assigned to undergo PFD-D and 84 to undergo PFD alone. The percentage of participants with complications within 6 months was 14% with PFD-D and 6% with PFD (adjusted odds ratio, 2.59; 95% confidence interval [CI], 0.86 to 7.84; P=0.11). At 24 months, the percentage of participants with clinical improvement was 58% with PFD-D and 46% with PFD; the mean (±SD) syrinx reduction was 3.08±2.33 mm and 1.22±1.79 mm, respectively; and the percentage of participants with repeat decompression was 3% and 14%. Changes in health-related quality of life were similar in the two groups. Conclusions: The percentage of participants with surgical complications did not differ significantly between those who underwent PFD-D and those who underwent PFD alone. Larger trials are needed to determine the relative benefits and risks of these two procedures. | ||
| 650 |
_aENFERMEDADES INFANTILES _953890 |
||
| 650 |
_aMEDICINA CLÍNICA HOSPITALARIA _953754 |
||
| 650 |
_aORTOPEDIA GENERAL _954409 |
||
| 650 |
_aPEDIATRÍA GENERAL _954247 |
||
| 650 |
_aTRASTORNOS DE LA COLUMNA VERTEBRAL _954410 |
||
| 650 | _aNEUROLOGÍA | ||
| 650 |
_aNEUROCIRUGÍA GENERAL _953668 |
||
| 700 |
_aShannon, Chevis N. _954411 |
||
| 700 |
_aBayman, Emine O. _954412 |
||
| 700 |
_aMeehan, Thanda _954413 |
||
| 700 |
_aKallem, Marisa _954414 |
||
| 700 |
_aAckerman, Laurie L. _954415 |
||
| 700 |
_aAdelson, P. David _954416 |
||
| 700 |
_aAhmed, Raheel _954417 |
||
| 700 |
_aAlbert, Gregory _954418 |
||
| 700 |
_aAldana, Philipp R. _954419 |
||
| 773 | 0 |
_022717 _922665 _dMassachusetts NEJM Group _oNEJM013 _tThe New England Journal of Medicine _wESSALUD _x0028-4793 |
|
| 942 |
_cARTICULOS _e2026-08-28 _zsqb |
||
| 999 |
_c22888 _d22888 |
||